172 related articles for article (PubMed ID: 25896652)
1. Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.
Bouchard BA; Chapin J; Brummel-Ziedins KE; Durda P; Key NS; Tracy PB
Blood; 2015 Jun; 125(23):3647-50. PubMed ID: 25896652
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.
Ayombil F; Abdalla S; Tracy PB; Bouchard BA
J Thromb Haemost; 2013 Aug; 11(8):1532-9. PubMed ID: 23710903
[TBL] [Abstract][Full Text] [Related]
3. Secretable human platelet-derived factor V originates from the plasma pool.
Camire RM; Pollak ES; Kaushansky K; Tracy PB
Blood; 1998 Nov; 92(9):3035-41. PubMed ID: 9787136
[TBL] [Abstract][Full Text] [Related]
4. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.
Duckers C; Simioni P; Spiezia L; Radu C; Dabrilli P; Gavasso S; Rosing J; Castoldi E
Blood; 2010 Jan; 115(4):879-86. PubMed ID: 19861681
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor.
Gould WR; Simioni P; Silveira JR; Tormene D; Kalafatis M; Tracy PB
J Thromb Haemost; 2005 Mar; 3(3):450-6. PubMed ID: 15748232
[TBL] [Abstract][Full Text] [Related]
6. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma.
Castoldi E; Duckers C; Radu C; Spiezia L; Rossetto V; Tagariello G; Rosing J; Simioni P
J Thromb Haemost; 2011 May; 9(5):959-68. PubMed ID: 21320286
[TBL] [Abstract][Full Text] [Related]
7. Parahemophilia: new insights into factor v deficiency.
Thalji N; Camire RM
Semin Thromb Hemost; 2013 Sep; 39(6):607-12. PubMed ID: 23893775
[TBL] [Abstract][Full Text] [Related]
8. Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII.
Shao Y; Wu W; Xu G; Wang X; Ding Q
Blood; 2019 Nov; 134(20):1745-1754. PubMed ID: 31558466
[TBL] [Abstract][Full Text] [Related]
9. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.
Thomassen MC; Castoldi E; Tans G; Magdeleyns EJ; Delaunoit C; Debusscher L; Van Assche KJ; Rosing J
Haematologica; 2003 Oct; 88(10):1150-6. PubMed ID: 14555311
[TBL] [Abstract][Full Text] [Related]
10. Factor V activity in apheresis platelets: Implications for management of FV deficiency.
Gupta GK; Hendrickson JE; Bahel P; Siddon AJ; Rinder HM; Tormey CA
Transfusion; 2021 Feb; 61(2):405-409. PubMed ID: 33166428
[TBL] [Abstract][Full Text] [Related]
11. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.
Ajzner E; Balogh I; Haramura G; Boda Z; Kalmár K; Pfliegler G; Dahlbäck B; Muszbek L
J Thromb Haemost; 2003 May; 1(5):943-9. PubMed ID: 12871359
[TBL] [Abstract][Full Text] [Related]
12. Management of bleeding in severe factor V deficiency with a factor V inhibitor.
Ardillon L; Lefrançois A; Graveleau J; Fouassier M; Ternisien C; Sigaud M; Fretigny M; Archambeaud I; Trossaërt M
Vox Sang; 2014 Jul; 107(1):97-9. PubMed ID: 24517203
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia.
Radu CM; Spiezia L; Bulato C; Gavasso S; Campello E; Sartorello F; Castoldi E; Simioni P
Br J Haematol; 2016 Nov; 175(3):517-524. PubMed ID: 27443583
[TBL] [Abstract][Full Text] [Related]
14. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.
Gould WR; Silveira JR; Tracy PB
J Biol Chem; 2004 Jan; 279(4):2383-93. PubMed ID: 14594814
[TBL] [Abstract][Full Text] [Related]
15. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
[TBL] [Abstract][Full Text] [Related]
16. Thrombin generation abnormalities in Quebec platelet disorder.
Brunet JG; Sharma T; Tasneem S; Liang M; Wilson MD; Rivard GE; Hayward CPM
Int J Lab Hematol; 2020 Dec; 42(6):801-809. PubMed ID: 32761872
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency.
Nuzzo F; Bulato C; Nielsen BI; Lee K; Wielders SJ; Simioni P; Key NS; Castoldi E
Haemophilia; 2015 Mar; 21(2):241-248. PubMed ID: 25470420
[TBL] [Abstract][Full Text] [Related]
18. "In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate.
Bulato C; Novembrino C; Anzoletti MB; Spiezia L; Gavasso S; Berbenni C; Tagariello G; Farina C; Nardini I; Campello E; Peyvandi F; Simioni P
Haemophilia; 2018 Jul; 24(4):648-656. PubMed ID: 29578313
[TBL] [Abstract][Full Text] [Related]
19. Factor V deficiency.
Asselta R; Peyvandi F
Semin Thromb Hemost; 2009 Jun; 35(4):382-9. PubMed ID: 19598066
[TBL] [Abstract][Full Text] [Related]
20. Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.
Duckers C; Simioni P; Spiezia L; Radu C; Gavasso S; Rosing J; Castoldi E
Blood; 2008 Nov; 112(9):3615-23. PubMed ID: 18695002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
